CML: Hagop Kantarjian on Treating Patients with the T315I Mutation

Oncology Times - OncTimes Talk

English - July 21, 2009 18:32 - 9 minutes - 8.39 KB - ★★★★ - 2 ratings
Science Health & Fitness Medicine oncology cancer medicine health news Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: KRAS-Driven Selection of Molecular Therapy for Metastatic Colorectal Cancer: Choosing Between Bevacizumab, Cetuximab, Panitumomab, or a Combination

Next Episode: Oropharyngeal Cancer: Better Outlook with HPV-Directed Therapies

Also: (1) Feasibility of patients becoming pregnant while having TKI treatment after having stable disease for at least two years; and (2) Decreased need for allogeneic transplant.